Non-Viral Transfection Reagents market Growth Opportunity and Industry Forecast to 2035

Comments · 74 Views

Given the increasing focus on genetically modified therapies, there is a consequent rise in the demand for efficient gene delivery vectors; in recent years, innovators are actively evaluating the potential of non-viral transfection agents.

Therefore, driven by the growing demand for cell and gene therapies, and the active ongoing efforts of industry stakeholders, the non-viral transfection reagents and systems market is anticipated to grow at a steady pace in the foreseen future.

 

The future opportunity within the non-viral transfection reagents and systems market has been analyzed across the following segments:

 

  • Non-Viral Based Transfection Methods
  • Chemical-based Methods
  • Physical-based Methods
  • Other Methods

 

  • End-Users
  • Academic And Research Institutions
  • Stem Pharmaceutical Companies
  • Other End-Users

 

  • Area of Application
  • Clinical Applications
  • Research Applications

 

  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

 

The “Non-Viral Transfection Reagents and Systems Market (2nd Edition), 2023-2035” report features the following companies, which we identified to be key players in this domain:

  • BEX
  • Bio-Rad Laboratories
  • BTX
  • Celsion Corporation
  • Genprex
  • Inovio Pharmaceuticals
  • MaxCyte
  • MilliporeSigma
  • NepaGene
  • OZ Biosciences
  • Thermo Fisher Scientific

 

Table of Contents

 

  1. Preface

 

  1. Executive Summary

 

  1. Introduction

 

  1. Non-Viral Transfection Reagents: Market Landscape

 

  1. Electroporation-Based Transfection Systems: Market Landscape

 

  1. Other Non-Viral Transfection Systems: Market Landscape

 

  1. Company Competitiveness Analysis

                    

  1. Technology Competitiveness Analysis

 

  1. Company Profiles

 

  1. Potential Strategic Partners

 

  1. Big Pharma Initiatives

 

  1. Patent Analysis

 

  1. Publication Analysis

 

  1. Roots Analysis Pricing Strategy Framework

 

  1. Market Sizing and Opportunity Analysis

 

  1. Executive Insights

 

  1. Conclusion

 

  1. Appendix 1: Tabulated Data

 

  1. Appendix 2: List of Companies and Organizations

 

To view more details on this report, click on the link:

https://www.rootsanalysis.com/reports/view_document/non-viral-transfection/307.html

 

Learn from experts:  do you know about these emerging industry trends?

Long-Acting Drug Delivery: A Novel Pharmacological Strategy to Deliver Therapeutic Modalities

Digital Therapies: The “Digital Pills” of current generation

 

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

 

Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting - the preferred research partner for global firms

 

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com

 

Comments